AstraZeneca is a global biopharma leader with a strong oncology, rare-disease and cardiovascular pipeline. It trades on London Stock Exchange under the ticker AZN, in the Pharmaceuticals sector.
Key Facts
| Item | Details |
|---|---|
| Ticker | AZN |
| Exchange | London Stock Exchange (AZN) |
| Sector | Pharmaceuticals |
| Headquarters | Cambridge, UK |
Bull Case & Risks
Bull Case
- An industry-leading oncology pipeline
- Strong volume growth and emerging markets
- Ambitious long-term revenue targets
Risks
- Pipeline and trial-outcome risk
- Drug-pricing pressure
Outlook
AstraZeneca is Europe’s most valuable pharma, powered by a deep oncology pipeline and ambitious growth targets.
Educational information only, not investment advice. Stocks carry risk including possible loss of principal; past performance does not guarantee future results.